H.C. Wainwright maintains Novavax at 'buy' with a price target of $35.00

  • Investing.com
H.C. Wainwright maintains Novavax at 'buy' with a price target of $35.00

An analyst from H.C. Wainwright maintained Novavax (NASDAQ: NVAX) at '' 'buy' and a price target of $35.00 from a prior price target of %currency%%price%.

Prior to this rating, Novavax had 2 buy ratings, 2 hold ratings, and 2 sell ratings.

For consensus analyst estimates and price targets on Novavax, click here. For more news on Novavax, click here.

Novavax's stock price closed at $9.52. They are up 5.31% in the last month and down -77.82% in the last 12 months.

According to Investing Pro, Novavax's fair value is $11.30, an upside of 18.70%. Novavax's fair value comes with a high degree of uncertainty, according to InvestingPro.

Check out Novavax's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles